Professor Ros Eeles


Ros is a Professor in Oncogenetics at The Institute of Cancer Research, London. She has led an extensive number of worldwide genetic trial collaborations repeatedly moving the boundaries in the world of prostate cancer and genetics. Ros discovered a significant proportion of the genes involved in prostate cancer. She offers consultations in cancer genetics to affected and unaffected individuals assessing their risk of inherited genetic variants which may increase their cancer risk. Samples can be sent off for testing. Prof Eeles work on the Whole Genome is not remunerated by the London Genetic Centre.

Dr Gabriella Christina Pichert–Eichenberger

MD, Consultant Cancer Genetics
Special Interest Cancer Genetics Services

Gabi worked initially in medical oncology but for many years has specialised in cancer genetics; providing cancer risk assessment, genetic counselling and advice on the management of individuals and families with an inherited predisposition to cancer, such as women with a personal and/or family history of breast cancer. Previously Consultant in Cancer Genetics at Guy`s and St Thomas NHS Foundation and Joint Lead for Cancer Genetic Services. Recently has been working in Berne.

Dr Lucy Side


Lucy is Clinical Lead for Genetics at University Hospitals Southampton, having completed her specialist training in Oxford, and spent 9 years as a Consultant in Genetics at Great Ormond St Hospital. She is a Senior Research Associate at UCL Institute for Women’s Health where her interest is in gynaecological cancer susceptibility, and has published over 100 papers in peer reviewed journals. She sees patients who are requesting testing for inherited alterations in genes that increase cancer risk.

Dr Tessa Homfray

Dr Homfray is a consultant in medical genetics and works at both Royal Brompton and Harefield hospitals. She has special interest in the genetics of cardiac disease and fetal cardiac genetics. She also specialises in prenatal diagnosis and runs clinics at St George's fetal medicine unit as well as the Harris Birthright unit at King's College London.

Dr James Ware

James Ware Honorary Consultant Cardiologist at Royal Brompton and Harefield Hospitals and a Reader in Genomic Medicine at Imperial College London, Group Head at the MRC London Institute of Medical Sciences, and . Dr Ware graduated from the University of Cambridge in 2000, and pursued general medical training in Cambridge, London and Geneva before appointment to specialist training in Cardiology in 2007. After a PhD at the MRC Clinical Sciences Centre (CSC), funded by a Fellowship from the Wellcome Trust, he was appointed an NIHR Clinical Lecturer in 2012, and undertook post-doctoral research at the MRC CSC, Imperial College, Harvard Medical School, and the Broad Institute. He was awarded a Wellcome Trust Intermediate Clinical Fellowship in 2015 and returned from Boston to start his own research group.James’ overarching research aims are to understand the impact of genetic variation on the heart and circulation, and to use genome information to improve patient care.


Medical Director

Michael is Medical Director of 90 Sloane Street. He attended the American Society of Clinical Oncology meetings in Chicago for 5 years with Prof Ros Eeles. The concept of doing Whole Genome Screening (WGS) and the setting up of The London Genetic Centre initially developed from these meetings. They both had the vision that General practice is the correct setting for Whole Genome Screening (WGS) of the asymptomatic population with the ideal for WGS to be done together with a Medical and not in isolation. Michael is co-lead with Prof Eeles of The London Genetic Centre Study (90S Study) of Whole Genome Screening in General Practice, the first of its type in the UK.
Hon Clinical Fellow The Institute of Cancer Research


Ann-Britt trained in GU/HIV medicine at Chelsea and Westminster before starting a career in Clinical Oncology. She has a MSc in Epidemiology with research experience at the CDC in the USA and NICE in London. She is currently a Clinical Research Fellow at The Institute of Cancer Research under the tutelage of Professor Eeles. Her MD focuses on the Integration of Germline Genetic Variations to Precision Medicine in Healthcare in screening and treatment paradigms.